Vicriviroc, a new CC-chemokine receptor 5 inhibitor for treatment of HIV: properties, promises and challenges

Author： Lenz Johannes Carl Christoph   Rockstroh Jürgen Kurt  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.6, Iss.9, 2010-09, pp. : 1139-1150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

S/GSK1349572, a new integrase inhibitor for the treatment of HIV: promises and challenges

By Lenz Johannes Carl Christoph   Rockstroh Jüürgen Kurt  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 4, 2011-04 ,pp. : 537-548

Informa Healthcare

Access to resources Recommend Favorite

Current Drug Design of Anti-HIV Agents Through the Inhibition of C-C Chemokine Receptor Type 5

By  

Current Computer - Aided Drug Design, Vol. 7, Iss. 4, 2011-12 ,pp. : 238-248

Bentham Science Publishers

Access to resources Recommend Favorite

Vicriviroc tastes VICTORy in HIV-1 treatment

By  

Inpharma, Vol. 1, Iss. 1625, 2008-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Recent Progress in the Discovery of New CCR5 and CXCR4 Chemokine Receptor Antagonists as Inhibitors of HIV-1 Entry. Part 2*

By  

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 4, Iss. 2, 2005-04 ,pp. : 133-152

Bentham Science Publishers

Access to resources Recommend Favorite

CC-Chemokine Receptors in Chronic Obstructive Pulmonary Disease

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 6, Iss. 2, 2007-06 ,pp. : 75-79

Bentham Science Publishers

Access to resources Recommend Favorite